MOLNUPIRAVIR--the new Merck drug Merck partnering with Ridgeback Pharma has asked for Emergency Use Authorization from the FDA for it's oral drug, Molnupiravir (Moll new peer ah veer). If 8 pills a day are taken for 5 days in the early days of an active COVID infection, they claim a 50% [Read More]